** Shares of radiology center operator RadNet RDNT.O fall 2% to $52 in extended trading
** RDNT says it is acquiring iCAD ICAD.O, an AI breast cancer detection software maker, in an all-stock acquisition valued about $103 million
** RDNT is offering $3.61/shr of ICAD common stock, representing a significant 87% premium to ICAD's closing price on Tuesday
** Shares of iCAD up 73% at $3.31 in extended trading
** Deal expected to close in the second or third quarter of 2025
** RDNT says the deal is expected to add over 1,500 healthcare-provider locations across 50 countries to its network
** As of last close, RDNT down 24% and ICAD up 5.5%, YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。